CytomX Therapeutics, Inc. (CTMX)
4.39
+0.15
(+3.54%)
USD |
NASDAQ |
Apr 10, 16:00
4.39
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Shareholders Equity (Quarterly) : 99.01M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| Rigel Pharmaceuticals, Inc. | 391.48M |
| REGENXBIO, Inc. | 102.73M |
| Ovid Therapeutics, Inc. | 130.66M |
| Olema Pharmaceuticals, Inc. | 478.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 152.50M |
| Total Liabilities (Quarterly) | 53.49M |
| Debt to Equity Ratio | 0.0428 |
| Current Ratio | 3.087 |
| Net Debt Paydown Yield | 0.18% |